| 000 | 01841 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517133305.0 | ||
| 264 | 0 | _c20180430 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1573-904X | ||
| 024 | 7 |
_a10.1007/s11095-017-2096-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBauerschlag, Dirk | |
| 245 | 0 | 0 |
_aDetection and Specific Elimination of EGFR _h[electronic resource] |
| 260 |
_bPharmaceutical research _c04 2017 |
||
| 300 |
_a696-703 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorescent Dyes _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoconjugates _xchemistry |
| 650 | 0 | 4 |
_aImmunoglobulin Variable Region _xchemistry |
| 650 | 0 | 4 |
_aIndoles _xchemistry |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aOrganosilicon Compounds _xchemistry |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aPhotochemotherapy |
| 650 | 0 | 4 |
_aSingle-Chain Antibodies _xchemistry |
| 650 | 0 | 4 |
_aSpectroscopy, Near-Infrared _xmethods |
| 650 | 0 | 4 | _aTheranostic Nanomedicine |
| 700 | 1 | _aMeinhold-Heerlein, Ivo | |
| 700 | 1 | _aMaass, Nicolai | |
| 700 | 1 | _aBleilevens, Andreas | |
| 700 | 1 | _aBräutigam, Karen | |
| 700 | 1 | _aAl Rawashdeh, Wa'el | |
| 700 | 1 | _aDi Fiore, Stefano | |
| 700 | 1 | _aHaugg, Anke Maria | |
| 700 | 1 | _aGremse, Felix | |
| 700 | 1 | _aSteitz, Julia | |
| 700 | 1 | _aFischer, Rainer | |
| 700 | 1 | _aStickeler, Elmar | |
| 700 | 1 | _aBarth, Stefan | |
| 700 | 1 | _aHussain, Ahmad Fawzi | |
| 773 | 0 |
_tPharmaceutical research _gvol. 34 _gno. 4 _gp. 696-703 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11095-017-2096-4 _zAvailable from publisher's website |
| 999 |
_c26772110 _d26772110 |
||